from the good-enough-for-the-likes-of-you dept.
John Bayko writes "Mentioned on Slashdot a couple of years ago, the drug dichloroacetate (DCA) has finally finished its first clinical trial against brain tumors in humans. Drug companies weren't willing to test a drug they could not patent, so money was raised in the community through donations, auctions, and finally government support, but the study was still limited to five patients. It showed extremely positive results in four of them. This episode raises the question of what happens to all the money donated to Canadian and other cancer societies, and especially the billions spent buying merchandise with little pink ribbons on it, if not to actual cancer research like this."
Vamman writes "If you've been following the drama surrounding the free release of MechWarrior4, then you're probably aware that the initial announcement, made last summer, was a bit premature. Now, nearly a year since that announcement was made, MekTek Studios has announced that Microsoft Legal has given clearance for the free release of Mechwarrior4. This move by Microsoft Games couldn't come at a better time for the community, as the owners of MechWarrior are attempting a reboot of the franchise."
Dr_Ken writes: ""Neuromancer is important because of its astounding predictive power. Gibson's core idea in the novel is the direct integration of man and computer, with all the possibilities (and horrors) that such a union entails. The book eventually sold more than 160 million copies, but bringing the book to popular attention took a long time and a lot of word-of-mouth. The sci-fi, community, however, was acutely aware of the novel's importance when it came out: Neuromancer ran the table on sci-fi's big three awards in 1984, winning the Hugo Award, the Philip K. Dick Memorial Award, and the Nebula Award.""